Cargando…
Extracellular vesicles in pancreatic cancer progression and therapies
Pancreatic cancer (PC) is one of the leading causes of cancer-related death worldwide due to delayed diagnosis and limited treatments. More than 90% of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). Extensive communication between tumour cells and other cell types in the tumour...
Autores principales: | Chang, Chao-Hui, Pauklin, Siim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528925/ https://www.ncbi.nlm.nih.gov/pubmed/34671031 http://dx.doi.org/10.1038/s41419-021-04258-7 |
Ejemplares similares
-
ROS and TGFβ: from pancreatic tumour growth to metastasis
por: Chang, Chao-Hui, et al.
Publicado: (2021) -
Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma
por: Pook, Hannah, et al.
Publicado: (2021) -
Editorial: Engineered extracellular vesicles for tissue repairing
por: Yu, Shiyi, et al.
Publicado: (2023) -
Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches
por: Truong, Linh-Huyen, et al.
Publicado: (2021) -
Revisiting 3D chromatin architecture in cancer development and progression
por: Feng, Yuliang, et al.
Publicado: (2020)